Granulocyte colony-stimulating factor (G-CSF) and Granulocyte-Macrophage colony stimulating factors (GM-CSF) are established therapeutics that promote the recovery of neutrophil and monocyte cell counts in neutropenic cancer patients undergoing chemotherapy particularly in the setting of infections [22]. This evidence concerns the gene CSF2 and cancer.